BioRich
Posted - 1 day ago
$MRKR have loved this one through thick and thin. Miss teaming them with their buddy $JNCE (since bought out). That's how old school I am on this one. Time to accumulate before movement. This will creep up over time. Solid buy and hold as we eye the finish line. Follow/Subscribe for more suggestions and perspective. Would love to hear yours too...that's how we find hidden gems and make money. Let's make some money! Cheers!
KingNeptune
Posted - 10/28/24
$GERN beautiful. Different sectors but always think $GERN and $CRMD track each other in their stage of clinical-to-production. Similar to how I saw $MRKR and $JNCE track each other in the past.
NVDAMillionaire
Posted - 3 months ago
$JNCE Jounce Therapeutics, Inc. (NASDAQ:JNCE): Transforming Cancer Treatment Through Innovative Immunotherapies http://beyondspx.com/2024/08/05/jounce-therapeutics-inc-nasdaqjnce-transforming-cancer-treatment-through-innovative-immunotherapies/
BioRich
Posted - 04/29/24
@TB_Goat my complete bad on this one. That might be why it's been red all of this time. For those that don't know, $JNCE was acquired by Concentra last year (although still showing up on stocktwits as stand alone stock) TB, great catch!
BioRich
Posted - 04/26/24
$MRKR ready for a breakout next week. Hopefully pulls $JNCE with it. $VTGN $TERN $CRMD due for a nice week also.
BioRich
Posted - 7 months ago
$MRKR nice movement. This should continue to move. Now we just need $JNCE to start getting these kind of gains.
BioRich
Posted - 03/28/24
$MRKR $JNCE and $CANF let's end the week strong
BioRich
Posted - 03/26/24
$PIRS is there any life with this one anymore? Sold for profit a few years back for around 3$ which is looking pretty good right now. Should have done the same with $JNCE and $MRKR although I think they still have legs as their trial results come in. The Jim Allison science is incredible
vrstock23
Posted - 11 months ago
$NBSE algos are your good friend to get this stock at cheap price. They bring down price for all stocks when there is lack of volume, they don't see if there is SA in progress or how much cash business has. $jnce was brought down below $1 and was finally closed at over $1.8 with offer from Tang capital. $frtx was brought below .6 and company decided to distribute cash with range of 0.9 to 1.1+ so stock just shoot to 50% + when news got published. Here also it looks very safe to me given cash burn is very minimal in last quarter. So only small risk is if management turns rough and give away cash to company it merges with cheap. But that would be very difficult to defend and they will be sued, so I think outcome will be like jnce or frtx. Remember they said in September giving $1 dividend is not in best interest of shareholders and they are working to benefit most to SH
Geddymd72
Posted - 11/24/23
$JNCE I seem to own 25 shares of JNCE^ which is untradable. I assume this is the CVR nontradable contigent Concentra (CVR)?
Stockholm111
Posted - 1 year ago
@John62 Email Kevin Tang and ask him take over... He saved investors when $JNCE management was about to screw retail over
fin_researcher
Posted - 10/26/23
#JounceTherapeutics, Inc. and #RedxPharma announced an all-share merger. $JNCE shareholders will own approximately 37% in the new Co. #Investors suspect that the pricing terms of the $JNCE & $REDX M&A deal are #unfair. https://11thestate.com/cases/jnce-redx-mna-investors-case
ikkydiphoenix
Posted - 1 year ago
As always Tang and Concentra like to play cheap eh. The point is that if $RAIN board is smart they will rise the price more than $JNCE and won't make the same mistake of $AVIR that has now lost 50%.. The biotech market is dead, interest rates are skyhigh, inflations is huge and there are two big wars going on in the world so refuse would be a move that only id10ts like Avir would make.
LabPsycho
Posted - 1 year ago
$KRON At this point, our best hope is for the upcoming clinical results to be an utter failure, and the company immediately ceases operation and liquidates / plans return cash to shareholders / get bought out above cash value. Past year examples are $JNCE $MGTA both up 200-300% from their bottoms. We'd be looking at $3.60-$4.00/share.
ChristmasYime
Posted - 1 year ago
@theonlyky nothing I’ve heard of, but not impossible. Keep an eye on SEC filings for +10% equity stock purchases, that’s what happened to $JNCE before buyout
BioRich
Posted - 07/26/23
@Justinwoj3 honestly, I haven't calculated $MRKR but have a nice position with them. Science is world renowned so I see them and $JNCE going through the roof (from a science perspective...reviewing the financials) Both are winners. First glance, I think $MRKR catches resistance around 12.80$
BioRich
Posted - 07/26/23
$ONON it night take 3 years but this will hit 160$/share. Watching $SRPT to push 108$ by EOM and 121$ by EOA(ugust). Good time to get into $VTGN. $MRKR in a heater...should be followed by $JNCE
WallStArb
Posted - 1 year ago
@cayman777 @bullwink @User123321 worst case with most risk is a combo with an unknown private bio - where they are used as a shell - too much unknown and subjective valuation. Best would be a larger bio like $NVS to buy for some premium over tangible book (net cash). Quick and dirty is a deal like $JNCE where it was 85% of net cash + CVR
ktrader1991
Posted - 1 year ago
$JNCE so we got another .021 lease termination per share. Nice
perchedcats
Posted - 1 year ago
$TECX tang capital making moves - they bought out jounce $JNCE not long ago, and recebtly made an offer for $AVIR
Stockamateur
Posted - 1 year ago
$JNCE why is this stock untradeable?
quickaspeter
Posted - 1 year ago
$JNCE $RAIN
Smp92
Posted - 1 year ago
$JNCE $RAIN yup! Was a great play!
nightstocker15
Posted - 1 year ago
$RAIN load up!! remember what Tang did recently at $JNCE he loaded up on shares then offered to buy out the rest at a nice premium! https://www.biopharmadive.com/news/jounce-rival-bid-tang-concentra-redx-merger/645090/
MarketBeat
Posted - 1 year ago
Jounce Therapeutics initiated by StockNews.com at hold. www.marketbeat.com/stocks/NASDAQ/JNCE/price-target/ $JNCE
BioRich
Posted - 05/31/23
$MRKR like i said if you have $JNCE you need $MRKR
Stockholm111
Posted - 05/26/23
$JNCE Looks like Tang's new remodeled company formerly known a Jounce Therapeutics is now Concentra Biosciences: https://www.concentrabiosciences.com/
Stockholm111
Posted - 05/26/23
$IMMP This is a long shot but if anyone knows about Tang Capital, they know that this guy buys out undervalued biotech plays in large large chunks (He single handedly bought out $JNCE ). I wonder if he's looking at IMMP ? https://www.buzzfile.com/business/Tang-Capital-Management,-LLC-858-200-3830
MarketBeat
Posted - 05/24/23
Jounce Therapeutics initiated by StockNews.com at hold. www.marketbeat.com/stocks/NASDAQ/JNCE/price-target/ $JNCE